HomeCompareSGXXF vs PFE

SGXXF vs PFE: Dividend Comparison 2026

SGXXF yields 5000000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SGXXF wins by $4.651129742658086e+43M in total portfolio value
10 years
SGXXF
SGXXF
● Live price
5000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.651129742658086e+43M
Annual income
$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00
Full SGXXF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SGXXF vs PFE

📍 SGXXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGXXFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGXXF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SGXXF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGXXF
Annual income on $10K today (after 15% tax)
$425,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, SGXXF beats the other by $39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGXXF + PFE for your $10,000?

SGXXF: 50%PFE: 50%
100% PFE50/50100% SGXXF
Portfolio after 10yr
$2.325564871329043e+43M
Annual income
$23,254,733,801,667,206,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SGXXF
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGXXF buys
0
PFE buys
0
No recent congressional trades found for SGXXF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGXXFPFE
Forward yield5000000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.651129742658086e+43M$49.6K
Annual income after 10y$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00$26,258.71
Total dividends collected$4.651117771440442e+43M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SGXXF vs PFE ($10,000, DRIP)

YearSGXXF PortfolioSGXXF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$500,010,700$500,000,000.00$9,153$693.39+$500.00MSGXXF
2$23,365,520,992,757$23,364,985,981,308.41$8,593$849.25+$23365520.98MSGXXF
3$1,020,442,548,175,215,100$1,020,417,547,067,752,800.00$8,336$1,066.78+$1020442548175.21MSGXXF
4$41,650,346,151,752,480,000,000$41,649,254,278,225,940,000,000.00$8,437$1,384.80+$41650346151752480.00MSGXXF
5$1,588,787,048,835,084,000,000,000,000$1,588,742,482,964,701,800,000,000,000.00$9,013$1,875.40+$1.588787048835084e+21MSGXXF
6$56,640,860,400,245,200,000,000,000,000,000$56,639,160,398,102,940,000,000,000,000,000.00$10,306$2,680.72+$5.66408604002452e+25MSGXXF
7$1,887,170,449,619,629,000,000,000,000,000,000,000$1,887,109,843,899,000,500,000,000,000,000,000,000.00$12,820$4,101.38+$1.887170449619629e+30MSGXXF
8$58,763,764,792,023,670,000,000,000,000,000,000,000,000$58,761,745,519,642,570,000,000,000,000,000,000,000,000.00$17,673$6,826.70+$5.876376479202367e+34MSGXXF
9$1,710,115,183,602,138,000,000,000,000,000,000,000,000,000,000$1,710,052,306,373,811,000,000,000,000,000,000,000,000,000,000.00$27,543$12,591.86+$1.710115183602138e+39MSGXXF
10$46,511,297,426,580,864,000,000,000,000,000,000,000,000,000,000,000$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00$49,560$26,258.71+$4.651129742658086e+43MSGXXF

SGXXF vs PFE: Complete Analysis 2026

SGXXFStock

Sound Global Ltd., an investment holding company, provides water and wastewater treatment solutions in the People's Republic of China, Singapore, and Bangladesh. It operates in three segments: Turnkey Projects and Services; Equipment Fabrications; and Operations and Maintenance of Water Supply and Wastewater Treatment Facilities. The company designs, constructs, operates, and maintains water and wastewater treatment facilities; and manufactures water and wastewater treatment equipment. It is also involved in the municipal water supply, wastewater treatment, and water recycling and reuse; research and development of water treatment technologies and provision of services of technology consultation; labor subcontracting activities; and leasing of construction machinery and equipment. In addition, the company plans, designs, constructs, and manages industrial zone water management systems, municipal wastewater projects, and water supply projects; and offers integrated solutions in various fields, such as industrial water supply, desalination, and industrial wastewater treatment and cyclical reuse, as well as centralized treatment for water supply and drainage in industrial zones. Further, it engages in the integration of water supply and drainage in villages and small towns; industrial and residential properties construction, and engineering design and construction activities; sale of building materials; leasing of properties; and computer software development activities. Additionally, the company offers equity investment management and consulting services; and property management and maintenance services. The company was formerly known as Epure International Ltd. and changed its name to Sound Global Ltd. in May 2010. Sound Global Ltd. was founded in 1993 and is based in Singapore. Sound Global Ltd. is a subsidiary of Sound Water (BVI) Limited.

Full SGXXF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SGXXF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGXXF vs SCHDSGXXF vs JEPISGXXF vs OSGXXF vs KOSGXXF vs MAINSGXXF vs JNJSGXXF vs MRKSGXXF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.